Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
Department of Critical Care Medicine, Hospital for Sick Children, Toronto, Ontario, Canada.
Pediatr Nephrol. 2023 Jul;38(7):2233-2242. doi: 10.1007/s00467-022-05823-8. Epub 2022 Nov 21.
Hyperchloremia has been associated with acute kidney injury (AKI) in critically ill adult patients. Data is limited in pediatric patients. Our study sought to determine if an association exists between hyperchloremia and AKI in pediatric patients admitted to the intensive care unit (PICU).
This is a single-center retrospective cohort study of pediatric patients admitted to the PICU for greater than 24 h and who received intravenous fluids. Patients were excluded if they had a diagnosis of kidney disease or required kidney replacement therapy (KRT) within 6 h of admission. Exposures were hyperchloremia (serum chloride ≥ 110 mmol/L) within the first 7 days of PICU admission. The primary outcome was the development of AKI using the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Secondary outcomes included time on mechanical ventilation, new KRT, PICU length of stay, and mortality. Outcomes were analyzed using multivariate logistic regression.
There were 407 patients included in the study, 209 in the hyperchloremic group and 198 in the non-hyperchloremic group. Univariate analysis demonstrated 108 (51.7%) patients in the hyperchloremic group vs. 54 (27.3%) in the non-hyperchloremic group (p = < .001) with AKI. On multivariate analysis, the odds ratio of AKI with hyperchloremia was 2.24 (95% CI 1.39-3.61) (p = .001). Hyperchloremia was not associated with increased odds of mortality, need for KRT, time on mechanical ventilation, or length of stay.
Hyperchloremia was associated with AKI in critically ill pediatric patients. Further pediatric clinical trials are needed to determine the benefit of a chloride restrictive vs. liberal fluid strategy. A higher resolution version of the Graphical abstract is available as Supplementary information.
高氯血症与危重症成年患者的急性肾损伤(AKI)有关。但相关数据在儿科患者中有限。我们的研究旨在确定 ICU 收治的儿科患者中高氯血症与 AKI 之间是否存在关联。
这是一项 ICU 收治时间超过 24 小时且接受静脉补液的儿科患者的单中心回顾性队列研究。如果患者在入院 6 小时内患有肾脏疾病或需要肾脏替代治疗(KRT),则将其排除在外。暴露因素为 ICU 入院后 7 天内血清氯浓度≥110mmol/L 的高氯血症。主要结局是采用肾脏病改善全球结局(KDIGO)标准定义的 AKI 的发生。次要结局包括机械通气时间、新的 KRT、PICU 住院时间和死亡率。采用多变量逻辑回归分析结局。
研究纳入 407 例患者,高氯血症组 209 例,非高氯血症组 198 例。单因素分析显示,高氯血症组 108 例(51.7%)患者与非高氯血症组 54 例(27.3%)患者发生 AKI(p<0.001)。多因素分析显示,高氯血症时 AKI 的比值比为 2.24(95%CI 1.39-3.61)(p=0.001)。高氯血症与死亡率、KRT 需求、机械通气时间或住院时间的增加无关。
危重症儿科患者中高氯血症与 AKI 相关。需要进一步开展儿科临床试验以确定限制氯盐与自由氯盐的液体策略的获益。高分辨率版本的图表摘要可在补充信息中查看。